DD220204A5 - Verfahren zur herstellung von 5-cyanoprostacylinen - Google Patents

Verfahren zur herstellung von 5-cyanoprostacylinen Download PDF

Info

Publication number
DD220204A5
DD220204A5 DD84264392A DD26439284A DD220204A5 DD 220204 A5 DD220204 A5 DD 220204A5 DD 84264392 A DD84264392 A DD 84264392A DD 26439284 A DD26439284 A DD 26439284A DD 220204 A5 DD220204 A5 DD 220204A5
Authority
DD
German Democratic Republic
Prior art keywords
group
atoms
general formula
free
straight
Prior art date
Application number
DD84264392A
Other languages
German (de)
English (en)
Inventor
Werner Skuballa
Helmut Dahl
Bernd Raduechel
Helmut Vorbrueggen
Olaf Loge
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DD220204A5 publication Critical patent/DD220204A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C07D307/937Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/41Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by hydrogenolysis or reduction of carboxylic groups or functional derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/02Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 2
    • C07D317/06Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 2 condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/30Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/061,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fats And Perfumes (AREA)
  • Liquid Developers In Electrophotography (AREA)
  • Control Of Transmission Device (AREA)
  • Epoxy Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Materials For Photolithography (AREA)
  • Cosmetics (AREA)
DD84264392A 1983-06-23 1984-06-21 Verfahren zur herstellung von 5-cyanoprostacylinen DD220204A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3322893A DE3322893A1 (de) 1983-06-23 1983-06-23 Neue prostacyclinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
DD220204A5 true DD220204A5 (de) 1985-03-27

Family

ID=6202360

Family Applications (1)

Application Number Title Priority Date Filing Date
DD84264392A DD220204A5 (de) 1983-06-23 1984-06-21 Verfahren zur herstellung von 5-cyanoprostacylinen

Country Status (20)

Country Link
US (1) US4894391A (fi)
EP (1) EP0130142B1 (fi)
JP (1) JPS6036477A (fi)
AT (1) ATE43589T1 (fi)
AU (1) AU562506B2 (fi)
CA (1) CA1252088A (fi)
CS (1) CS243491B2 (fi)
DD (1) DD220204A5 (fi)
DE (2) DE3322893A1 (fi)
DK (1) DK299584A (fi)
ES (1) ES533642A0 (fi)
FI (1) FI82040C (fi)
GR (1) GR82122B (fi)
HU (1) HU191150B (fi)
IL (1) IL72198A (fi)
NO (1) NO158874C (fi)
NZ (1) NZ208623A (fi)
PH (1) PH22431A (fi)
SU (1) SU1450739A3 (fi)
ZA (1) ZA844766B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63174984A (ja) * 1987-01-16 1988-07-19 Nissan Chem Ind Ltd シアノプロスタサイクリン類の合成法
ATE122563T1 (de) * 1989-07-27 1995-06-15 Ueno Seiyaku Oyo Kenkyujo Kk Verwendung von 15-keto-prostansäure-derivaten zur herstellung eines medikaments für die verbesserung der ausscheidung des kaliumions.
WO1998037895A1 (fr) * 1997-02-27 1998-09-03 Toray Industries, Inc. Medicaments permettant d'ameliorer la circulation pulmonaire
US7008307B2 (en) * 2003-09-02 2006-03-07 Wolff Industries Apparatus for sharpening a circular blade
US7776896B2 (en) * 2007-03-28 2010-08-17 Bayer Schering Pharma Aktiengesellschaft 5-cyano-prostacyclin derivatives as agents for the treatment of influenza a viral infection
EP1988087A1 (en) * 2007-03-28 2008-11-05 Bayer Schering Pharma Aktiengesellschaft Novel 5-cyano-prostacyclin derivatives and their use as agents for the treatment of autoimmune diseases
US20080242713A1 (en) * 2007-03-28 2008-10-02 Bayer Schering Pharma Aktiengesellschaft Novel 5-cyano-prostacyclin derivatives as agents for the treatment of autoimmune diseases
EP1975163A1 (en) * 2007-03-28 2008-10-01 Bayer Schering Pharma Aktiengesellschaft Novel 5-cyano-prostacyclin derivatives and their use as agents for the treatment of influenza a viral infection

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3953435A (en) * 1974-01-10 1976-04-27 Ono Pharmaceutical Company Aldehyde derivatives of prostaglandins
DE2753244A1 (de) * 1977-11-25 1979-06-07 Schering Ag Neue prostacyclinderivate und verfahren zu ihrer herstellung
US4565827A (en) * 1980-10-27 1986-01-21 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. 7-Substituted PGI2 -derivatives and pharmaceutical compositions containing them
DE3041601A1 (de) * 1980-10-31 1982-06-16 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue prostacyclinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4475681A (en) * 1982-05-24 1984-10-09 The Micromanipulator Co., Inc. Bonder apparatus

Also Published As

Publication number Publication date
SU1450739A3 (ru) 1989-01-07
NO842534L (no) 1984-12-27
IL72198A0 (en) 1984-10-31
ZA844766B (en) 1985-02-27
GR82122B (fi) 1984-12-13
JPS6036477A (ja) 1985-02-25
NO158874C (no) 1988-11-09
FI842524A0 (fi) 1984-06-21
US4894391A (en) 1990-01-16
NZ208623A (en) 1987-11-27
HUT34180A (en) 1985-02-28
EP0130142B1 (de) 1989-05-31
NO158874B (no) 1988-08-01
CA1252088A (en) 1989-04-04
CS474184A2 (en) 1985-08-15
AU562506B2 (en) 1987-06-11
CS243491B2 (en) 1986-06-12
DK299584A (da) 1984-12-24
ES8503348A1 (es) 1985-03-01
PH22431A (en) 1988-09-12
AU2978684A (en) 1985-01-03
DK299584D0 (da) 1984-06-19
DE3478435D1 (en) 1989-07-06
EP0130142A1 (de) 1985-01-02
ATE43589T1 (de) 1989-06-15
FI82040B (fi) 1990-09-28
FI82040C (fi) 1991-01-10
ES533642A0 (es) 1985-03-01
FI842524A (fi) 1984-12-24
DE3322893A1 (de) 1985-01-03
HU191150B (en) 1987-01-28
IL72198A (en) 1987-09-16

Similar Documents

Publication Publication Date Title
EP0055208A2 (de) Neue Carbacycline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
CH635827A5 (de) Neue strukturanaloge der prostaglandine.
EP0119949B1 (de) Neue Carbacycline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP0099538B1 (de) Neue Carbacycline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP0051558B1 (de) Prostacyclinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DD220204A5 (de) Verfahren zur herstellung von 5-cyanoprostacylinen
EP0069692B1 (de) Neue Carbacycline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP0105288B1 (de) Carbacycline, herstellung und verwendung
DE3104044A1 (de) Neue prostacyclin-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3221193A1 (de) Neue carbacyclinester, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP0098794B1 (de) Neue Carbacycline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP0113311B1 (de) 5-Fluorcarbacycline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP0086404A1 (de) Neue Carbacycline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE3209702A1 (de) Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
CH638195A5 (de) Prostacyclinanaloge.
DD233997A5 (de) Verfahren zur herstellung von carbacyclinen
DE3340988A1 (de) 20-alkyl-7-oxoprostacyclinderivate und verfahren zu ihrer herstellung
DD202010A5 (de) Verfahren zur herstellung neuer carbacycline
DD234414A5 (de) Verfahren zur herstellung neuer carbacycline
CH635836A5 (de) Therapeutisch wirksame prostacyclin-analoge.
DE3320014A1 (de) Neue 5-azaprostacyclinderivate, ihre herstellung und anwendung
DE3306125A1 (de) Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3308561A1 (de) 19,20-methylenprostacyclinderivate und verfahren zu ihrer herstellung
EP0139731A1 (de) 5-äthinyl-prostacycline, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
DE3610556A1 (de) 7-oxoprostacyclinderivate und verfahren zu ihrer herstellung